Therapeutic area: Cardiology/Vascular Disease

Upcoming
How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient
June 22, 2020
6:00 p.m. EDT
Watch Now
How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient
March 9, 2020
Watch Now
How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient
March 4, 2020
Watch Now
Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?
February 13, 2020
Watch Now
Optimizing Heart Failure Therapy - The Time is Now: Putting Evidence into Practice
December 5, 2019
Watch Now
15 min. Highlights from The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?
October 26, 2019
Watch Now
Women and CV Disease: Closing Care Gaps & Assessing Risk
July 22, 2019
Watch Now
Highlights from the Latest ODYSSEY OUTCOMES Data: The Role of PCSK9 Inhibition Post-ACS
February 21, 2019
Watch Now
Highlights from the Latest ODYSSEY OUTCOMES Data: The Role of PCSK9 Inhibition Post-ACS
February 13, 2019
Watch Now
Faits saillants des toutes dernières données de l’étude ODYSSEY OUTCOMES : Rôle de l’inhibition de la PCSK9 après un SCA
February 13, 2019
Watch Now
Traitement anticoagulant chez les patients atteints d’insuffisance rénale
November 14, 2018
Watch Now
Anticoagulation in Patients with Renal Impairment
October 10, 2018
Watch Now
Prise en charge de l’anticoagulothérapie prolongée dans les cas de TEV
June 5, 2018
Watch Now
Managing Extended Anticoagulant Therapy in VTE
June 5, 2018
Watch Now
Ask the Experts: Hot Topics in Heart Failure Management
May 15, 2018